149 related articles for article (PubMed ID: 9066700)
1. MIB1 (Ki-67) expression in non-Hodgkin's lymphomas.
Kalogeraki A; Tzardi M; Panagiotides I; Koutsoubi K; Bolioti S; Rontogianni D; Stefanaki K; Zois E; Karidi E; Darivianaki K; Delides G; Kanavaros P
Anticancer Res; 1997; 17(1A):487-91. PubMed ID: 9066700
[TBL] [Abstract][Full Text] [Related]
2. Determination of the growth fraction in non-Hodgkin's lymphomas by monoclonal antibody Ki-S5 directed against a formalin-resistant epitope of the Ki-67 antigen.
Kreipe H; Wacker HH; Heidebrecht HJ; Haas K; Hauberg M; Tiemann M; Parwaresch R
Am J Pathol; 1993 Jun; 142(6):1689-94. PubMed ID: 7685150
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of Ki-67 antigen expression in non-Hodgkin's lymphomas.
Szczuraszek K; Mazur G; Jeleń M; Dziegiel P; Surowiak P; Zabel M
Anticancer Res; 2008; 28(2A):1113-8. PubMed ID: 18507062
[TBL] [Abstract][Full Text] [Related]
4. Significance of cell proliferation index in assessing histological prognostic categories in Hodgkin's disease. An immunohistochemical study with Ki67 and MIB-1 monoclonal antibodies.
Abele MC; Valente G; Kerim S; Navone R; Onesti P; Chiusa L; Resegotti L; Palestro G
Haematologica; 1997; 82(3):281-5. PubMed ID: 9234572
[TBL] [Abstract][Full Text] [Related]
5. Proliferating cell nuclear antigen (PCNA) expression in childhood lymphomas.
Kalmanti M; Kanavaros P; Sakalidou A; Tzardi M; Datseris G; Bolonaki E; Kalmantis T; Kazlaris E; Delides G
Acta Morphol Hung; 1992; 40(1-4):215-21. PubMed ID: 1365765
[TBL] [Abstract][Full Text] [Related]
6. The pattern of Ki-67 and bcl-2 expression in lymphoid malignancies.
Wang PL; Peh SC
Malays J Pathol; 1997 Jun; 19(1):59-64. PubMed ID: 10879243
[TBL] [Abstract][Full Text] [Related]
7. Growth fractions in canine non-Hodgkin's lymphomas as determined in situ by the expression of the Ki-67 antigen.
Fournel-Fleury C; Magnol JP; Chabanne L; Ghernati I; Marchal T; Bonnefond C; Bryon PA; Felman P
J Comp Pathol; 1997 Jul; 117(1):61-72. PubMed ID: 9263844
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical detection of cell-cycle associated markers on paraffin embedded and formalin fixed needle biopsies of prostate cancer: correlation of p120 protein expression with AgNOR, PCNA/cyclin, Ki-67/MIB1 proliferation-scores and Gleason gradings.
Botticelli AR; Casali AM; Botticelli L; Zaffe D
Eur J Histochem; 1998; 42(1):41-8. PubMed ID: 9615190
[TBL] [Abstract][Full Text] [Related]
9. [Malignant and benign lymphomas: histologic classification and immunomorphologic studies. Results of 838 cases].
Radaszkiewicz T
Wien Klin Wochenschr; 1980 Dec; 92(23):819-33. PubMed ID: 6985528
[TBL] [Abstract][Full Text] [Related]
10. A comparison of Ki67 immunostaining and nucleolar organiser region staining in non-Hodgkin's lymphoma. P. A. Hall, J. Crocker, A. Watts, A. G. Stansfeld. Histopathology 1988; 12; 373-381 & Detection of the Ki67 antigen in fixed and wax embedded sections with the monoclonal antibody MIB1.D. McCormick, H. Chong, C. Hobbs, C. Datta &P. A. Hall. Histopathology 1993; 22; 355-360.
Hall PA
Histopathology; 2002 Sep; 41(3A):111-4; discussion 114. PubMed ID: 12405939
[No Abstract] [Full Text] [Related]
11. Comparison between the monoclonal antibodies Ki-67 and PC10 in 125 malignant lymphomas.
Sabattini E; Gerdes J; Gherlinzoni F; Poggi S; Zucchini L; Melilli G; Grigioni F; Del Vecchio MT; Leoncini L; Falini B
J Pathol; 1993 Apr; 169(4):397-403. PubMed ID: 8099126
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical staining for DNA topoisomerase II in non-Hodgkin's lymphomas.
Holden JA; Perkins SL; Snow GW; Kjeldsberg CR
Am J Clin Pathol; 1995 Jul; 104(1):54-9. PubMed ID: 7611182
[TBL] [Abstract][Full Text] [Related]
13. Flow cytometric S-phase fraction as a complementary biological parameter for the cytological grading of non-Hodgkin's lymphoma.
Pinto AE; Cabeçadas J; Nóbrega SD; Mendonça E
Diagn Cytopathol; 2003 Oct; 29(4):194-9. PubMed ID: 14506670
[TBL] [Abstract][Full Text] [Related]
14. Low versus high cell turnover in diffusely growing non-Hodgkin's lymphomas.
Spina D; Leoncini L; Del Vecchio MT; Megha T; Minacci C; Poggi SA; Pileri S; Tosi P; Kraft R; Laissue JA
J Pathol; 1995 Dec; 177(4):335-41. PubMed ID: 8568587
[TBL] [Abstract][Full Text] [Related]
15. Analysis of proliferating cell fraction determined by monoclonal antibody to M1-subunit ribonucleotide reductase and Ki-67 in relation to p53 protein expression in fine-needle aspirates from non-Hodgkin's lymphomas.
Sviatoha V; Tani E; Rassidakis G; Tribukait B; Kleina R; Skoog L
Cytopathology; 2000 Oct; 11(5):290-301. PubMed ID: 11014656
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis and grading of non-Hodgkin's lymphomas on fine needle aspiration cytology.
Mathur S; Dawar R; Verma K
Indian J Pathol Microbiol; 2007 Jan; 50(1):46-50. PubMed ID: 17474258
[TBL] [Abstract][Full Text] [Related]
17. Role and prognostic significance of the Ki-67 index in non-Hodgkin's lymphoma.
Broyde A; Boycov O; Strenov Y; Okon E; Shpilberg O; Bairey O
Am J Hematol; 2009 Jun; 84(6):338-43. PubMed ID: 19384938
[TBL] [Abstract][Full Text] [Related]
18. Proliferating cell nuclear antigen (PCNA) in non-Hodgkin's lymphomas: correlation with working formulation and Kiel classification in formalin-fixed paraffin-embedded material.
Rabenhorst SH; Burini RC; Schmitt FC
Pathology; 1996 Jan; 28(1):12-6. PubMed ID: 8714262
[TBL] [Abstract][Full Text] [Related]
19. [Histological classification of malignant non-Hodgkin's lymphomas and patient survival: the Kiel classification versus the working formulation].
Nizze H; Bühring U
Verh Dtsch Ges Pathol; 1992; 76():110-6. PubMed ID: 1283239
[TBL] [Abstract][Full Text] [Related]
20. Quantitative analysis of cellular proliferative activity in 35 T-cell non-Hodgkin's lymphomas. Use of proliferating cell nuclear antigen and Ki-67 (MIB-1) antibodies and nucleolar organizer regions.
Caulet-Maugendre S; Patey M; Granier E; Joundi A; Gentile A; Caulet T
Anal Quant Cytol Histol; 1996 Oct; 18(5):337-44. PubMed ID: 8908304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]